| Financial Year |
March 31 2023 |
| Monetary Funds |
8,329,901,223.41 |
| Held-for-trading Financial Assets |
25,338,425,923.88 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
-- |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
-- |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
714,687,046.43 |
| Investment Properties |
-- |
| Fixed Assetes |
310,618,382.49 |
| Under-construction Projects |
30,650,375.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,567,228.43 |
| R&D expenses |
-- |
| Goodwill |
3,640,479,698.73 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
360,617,867.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
-- |
| Total Assets |
53,271,307,664.48 |
| Short-Term Loans |
57,650,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
411,356,739.82 |
| Taxes Payable |
124,797,869.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
-- |
| Long-term Loans |
-- |
| Bonds Payable |
11,480,390,123.65 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,552,375.00 |
| Deferred Income Tax Liabilities |
149,670,823.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
33,755,465,416.69 |
| Paid-In Capital(Or Share Stock) |
2,261,423,642.00 |
| Capital Surplus |
15,900,853,041.32 |
| Surplus Reserve |
29,574,390.68 |
| LESS:Treasury Stock |
718,853,958.85 |
| Undistributed Profits |
904,009,678.51 |
| Minority Stockholder's Interest |
79,243,614.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,436,598,633.33 |
| Owner's Equity（Stockholder's Equity） |
19,515,842,247.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,271,307,664.48 |
